Factors impeding the discovery of an intervention-based treatment for type 1 diabetes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 183, Issue 1, Pages 1-7
Publisher
Wiley
Online
2015-05-19
DOI
10.1111/cei.12656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Human Leukocyte Antigen Class I in Endocrine and Exocrine Pancreatic Tissue at Onset of Type 1 Diabetes
- (2015) Oskar Skog et al. AMERICAN JOURNAL OF PATHOLOGY
- The Streetlight Effect in Type 1 Diabetes
- (2015) Manuela Battaglia et al. DIABETES
- Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro
- (2015) Lars Krogvold et al. DIABETES
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?
- (2015) Adrian M. Di Bisceglie et al. HEPATOLOGY
- Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes
- (2014) Teresa Rodriguez-Calvo et al. DIABETES
- Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
- (2014) Sefina Arif et al. DIABETES
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune therapy for treating type 1 diabetes: challenging existing paradigms
- (2014) Jay S. Skyler JOURNAL OF CLINICAL INVESTIGATION
- Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
- (2013) J. M. Lachin et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings
- (2013) Alberto Pugliese et al. PEDIATRIC DIABETES
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Anti-CD3 antibodies for type 1 diabetes: beyond expectations
- (2011) Jean-François Bach LANCET
- Insulitis in human type 1 diabetes
- (2011) Peter In't Veld Islets
- Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes
- (2010) G. S. Eisenbarth DIABETES
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- Combination therapies for Type 1 diabetes: why not now?
- (2010) Matthias von Herrath Immunotherapy
- Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
- (2010) Jason L. Gaglia et al. JOURNAL OF CLINICAL INVESTIGATION
- Update on Worldwide Efforts to Prevent Type 1 Diabetes
- (2009) Jay S. Skyler et al. Annals of the New York Academy of Sciences
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started